GenoPalate's last reported valuation, Oct 2022. Nothing priced has surfaced since.
- ·Watch GenoPalate: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
GenoPalate funding history
7 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2026 | Seed Round | $250K | ▮ | ▮ |
| Oct 2024 | Seed Round | $3.0M | ▮ | ▮ |
| Oct 2022 | Early Stage VC | $6.0M | ▮ | ▮ |
| Dec 2020 | Seed Round | $4.0M | ▮ | ▮ |
| Dec 2019 | Seed Round | $1.0M | ▮ | ▮ |
| Nov 2018 | Seed Round | $709K | ▮ | ▮ |
| + 1 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
GenoPalate valuation
GenoPalate's last reported valuation was $21 million in Oct 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has GenoPalate raised?
GenoPalate has raised $13.3 million across 7 recorded rounds since 2018. The largest was a $709,095 seed round in Nov 2018; the most recent was a $250,000 seed round in Feb 2026.
GenoPalate has filed 7 Form Ds with the SEC since 2018, most recently in Dec 2024 ($3 million sold to 4 investors).
How GenoPalate's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For GenoPalate, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about GenoPalate
- What is GenoPalate worth?
- GenoPalate is valued at $21.0M as of Oct 2026. GenoPalate's last reported valuation, Oct 2022. Nothing priced has surfaced since.
- How much has GenoPalate raised?
- GenoPalate has raised $13.3M in total funding across 7 recorded rounds.
- When did GenoPalate last raise?
- GenoPalate last raised in Feb 2026 (Seed Round), raising $250K.